+39 02 610346.1 - info@newron.com

Latest press releases

  • 17Feb
    Newron Expands Global Rett Syndrome Burden of Illness Survey Outreach to Europe and Australia


  • 4Feb
    Newron Pharmaceuticals to Present at the 22nd Annual BIO CEO & Investor Conference in New York

  • 9Jan
    Newron announces initiation of new clinical trial with Evenamide in patients with schizophrenia, following approval of plan by FDA


  • 9Dec
    Newron Pharmaceuticals to Request Type A FDA Meeting Prior to Unblinding of STARS Clinical Trial Data


  • 25Nov
    Newron Receives Second Tranche from Financing Agreement with European Investment Bank (EIB)


  • 19Nov
    Newron Receives FDA Rare Pediatric Disease Designation for Sarizotan for the Treatment of Rett Syndrome


View All

Newron share price


  • 20Apr
    H.C. Wainwright Annual Global Life Sciences Conference

    April 19-21, 2020 - London, UK

  • 21Apr
    Kempen Life Sciences Conference

    April 21-22, 2020 - Amsterdam, The Netherlands

  • 21Apr
    Swiss Biotech Day 2020

    April 21, 2020 - Basel, Switzerland

View Event Calendar